1 asset in IDH-Mutant Anaplastic Astrocytoma
Therapeutic assets addressing IDH-Mutant Anaplastic Astrocytoma, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Olutasidenib IDH-Mutant Anaplastic Astrocytoma | Rigel Pharmaceuticals | P2 | CCC (53) |